2Chu X, Shen M, Xie F, et al. An X chromosome-wide associa- tion analysis identifies variants in GPRI74 as a risk factor for Graves' disease[J]. J Med Genet,2013, 50(7):479-485.
3Lopes MH. Therapy with 121Ⅰ to hyperthyroidism Graves disease resolution: dose selection[J]. Arq Bras Endocrinol Metabol, 2007, 51(7) : 1031-1033.
4Charkes ND. Retreatment of Graves' disease with radioiodine131Ⅰ [J]. J Nucl Med,1999, 40(1): 215-216.
5Hautzel H, Piser E, Yazdan-Doust N, et al. Qualitative and quantitative impact of protective glucocorticoid therapy on the ef- fective 131Ⅰ half-life in radioiodine therapy for Graves disease[J]. J Nuel Med,2010,51(12) :1917-1922.
